FDA rejects emergency use authorisation for Covaxin in a setback for India-made jab
FDA suggests Biologics Licence Application - a "full approval" mechanism by the FDA for drugs and vaccines - route for approval in the United States
Jun 11, 2021, 11:50 AM IST
Delta variant might cause infections despite Covishield, Covaxin shots: AIIMS study
According to separate studies by AIIMS and the National Centre for Disease Control, the 'delta' variant is capable of infecting people even after they have received both doses of the Covaxin or Covishield vaccines. The studies, however, have not been peer-reviewed as yet.
Jun 10, 2021, 10:36 AM IST
Covaxin phase 4 trials to be conducted soon, phase 3 data to be out in July: Bharat Biotech
Bharat Biotech is going to conduct a phase 4 trial of its COVID-19 vaccine, Covaxin, in order to check the real-world effectiveness. The company revealed that the results for the phase 3 trial will be published next month.
Jun 10, 2021, 07:36 AM IST
'Not scientifically designed': Bharat Biotech rejects study that claimed Covaxin less effective than Covishield
The Hyderabad-based COVID vaccine manufacturer also said that it will publish the phase 3 trial data in July and after that, it will be applying for the full licensure of COVAXIN.
Jun 09, 2021, 19:16 PM IST
Indian govt caps the maximum price of Coronavirus vaccine for private hospitals
Amid allegations of profiteering by the opposition, the Center has fixed the maximum price that private hospitals can charge for COVID vaccines. Covishield has been priced at ₹780 per dose, Russian vaccine Sputnik-V at ₹1,145 per dose and indigenously manufactured Covaxin at ₹1,410 per dose.
Jun 09, 2021, 08:42 AM IST
Covishield at Rs 780 and Covaxin at Rs 1410: Centre revises vaccine rates for private hospitals
The maximum price of Covishield for private COVID-19 Vaccination Centres (CVCs) has been fixed at Rs 780 per dose, while that of Covaxin is Rs 1,410 per dose and Sputnik V Rs 1,145 per dose.
Jun 08, 2021, 22:38 PM IST
Covaxin maker Bharat Biotech's Hyderabad campus gets CISF security cover
CISF will take over the security of the Bharat Biotech campus in Hyderabad, Telangana. Total 64 CISF personnel, headed by an inspector-level officer, will provide security starting June 14.
Jun 08, 2021, 20:34 PM IST
Placed orders for 44 crore doses of Covishield and Covaxin after PM's announcement of new vaccine policy: Govt
These 44 crore doses of COVID-19 vaccines will be delivered by their makers between August and December 2021, the Union Health Ministry said.
Jun 08, 2021, 18:05 PM IST
Tokyo Games: Olympic-bound athletes, officials to receive 2nd dose of COVID-19 vaccine after 4 weeks
Last month, a government panel had recommended that the dosage interval of Serum Insititute of India’s Covishield vaccine be increased to 12-16 weeks. However, the gap between the two doses of Bharat Biotech’s Covaxin is four weeks.
Jun 08, 2021, 08:32 AM IST
Keep Covaxin jabs only as second dose for 18-44 age category, Delhi directs private hospitals
Delhi government on Sunday (June 6) directed private hospitals and nursing homes to administer Covaxin only to those eligible for the second dose in respect of the 18-44 age group in the month of June.
Jun 06, 2021, 22:35 PM IST
Bharat Biotech ties up with Ocugen for Covaxin manufacture, sale in Canada
Ocugen Inc. and Bharat Biotech on Thursday (June 3, 2021) announced that they have entered into an amendment to their Co-development, Supply, and Commercialization Agreement to expand Ocugen's exclusive territory to commercialize Covaxin.
Jun 04, 2021, 07:58 AM IST
AIIMS Delhi to start Covaxin trials on children in few days: Sources
The pediatric trials for Covaxin started in AIIMS Patna on Tuesday after Bharat Biotech`s COVID-19 vaccine received the Drugs Controller General of India (DCGI) nod to conduct clinical trials on children on May 11.
Jun 03, 2021, 17:40 PM IST
Exclusive: Myths surrounding COVID-19 vaccination BUSTED - From is it safe for menstruating women to vaccine leading to infertility!
Myths surrounding the COVID vaccine doing the rounds on social media have made people sceptical about getting jabbed.
Jun 03, 2021, 16:46 PM IST
Supreme Court slams Centre's vaccination policy for 18-44 year-olds, demands full purchase list
The bench noted that the Centre its May 9 affidavit stated that every state/UT shall provide vaccination free of cost to its population and said that it is important that individual governments confirm/deny this position before the apex court.
Jun 02, 2021, 19:07 PM IST
Waiting for Covaxin's approval by WHO, says Vietnam envoy
Speaking from Bengaluru to Zee Media, Pham Sanh Chau said, "Covaxin is not approved yet by WHO for emergency use, that is why we are waiting for this approval and then we will intensify the discussion.”
Jun 02, 2021, 15:49 PM IST
COVID Alert: Delhi left with 3,190 vaccine doses for 18-44 age group
Delhi is left with 3,190 COVID vaccine doses in its balance stock out of which 1,120 doses are of Covaxin and 2,070 of Covishield reserved for the age group 18-44 years.
May 31, 2021, 23:21 PM IST
India to import vaccines to speed up vaccination of entire population
Govt. of India, through NEGVAC, is doing regular interaction with national and international vaccine manufacturers like Pfizer, Moderna etc. to make the COVID-19 vaccines available in-country.
May 28, 2021, 23:31 PM IST
Claims of Bharat Biotech producing 6 crore Covaxin doses monthly false: Centre
The Centre said that the production would reach nearly 10 crore doses per month by September.
May 28, 2021, 21:46 PM IST
COVID-19 Vaccine: Here's how it is manufactured and distributed before reaching you
All batches of vaccines supplied to State and Central Governments are based on the allocation framework received from the Government of India.
May 28, 2021, 18:35 PM IST
